Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Pradeep Bista"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Christopher Morabito, Chris Stevens, Jou-Ku Chung, Rafif Dagher, Pradeep Bista, Kristine Bernard, Pamela Gustafson, Michele Gunsior, Andy Nichols
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:AB136
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:AB142
Publikováno v:
Journal of Allergy and Clinical Immunology. 149:AB167
Autor:
Chi B. Vu, Min Ding, Ericka L. Benson, Robert Kleemann, Martine C. Morrison, Rick B. Vega, Diana Y. Lee, Maisy Yeager, Michael R. Jirousek, Andrew J. Nichols, Guosheng Liang, Teake Kooistra, Michael Zimmer, Jill C. Milne, Dominic Picarella, Peter Y. Wielinga, Feng Liu, Jay D. Horton, Pradeep Bista
Publikováno v:
Hepatology Communications
CAT-2003 is a novel conjugate of eicosapentaenoic acid (EPA) and niacin designed to be hydrolyzed by fatty acid amide hydrolase to release EPA inside cells at the endoplasmic reticulum. In cultured liver cells, CAT-2003 blocked the maturation of ster
Autor:
Andrew J. Nichols, John F. Reilly, Mitchell E. Allen, David Brown, Chi B. Vu, Alexander H. Thomson, Diana Lee, Justin B. Perry, Pradeep Bista
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1859:e48-e49
Autor:
Robert H. Scannevin, Kenneth J. Rhodes, Mi Young Jung, Matvey E. Lukashev, Sowmya Chollate, Melanie N. Shackett, Masayuki Yamamoto, Weike Zeng, Sarah Ryan, Hiral Patel, Pradeep Bista
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 341:274-284
Oxidative stress is central to the pathology of several neurodegenerative diseases, including multiple sclerosis, and therapeutics designed to enhance antioxidant potential could have clinical value. The objective of this study was to characterize th
Autor:
Ralf A. Linker, Robert H. Scannevin, Rebecca Conrad, Matvey E. Lukashev, Sowmya Chollate, Pradeep Bista, Sarah Ryan, Ralf Gold, Gisa Ellrichmann, Alex Buko, Kate Dawson, De-Hyung Lee, Weike Zeng, Susan Goelz, Xiaoping Hronowsky, Wolfgang Brück, Anne M van Dam, Stefan Wiese
Publikováno v:
Linker, R A, Lee, D-H, Ryan, S, van Dam, A M, Conrad, R, Bista, P, Zeng, W, Hronowsky, X, Buko, A, Chollate, S, Ellrichmann, G, Brück, W, Dawson, K, Goelz, S, Wiese, S, Scannevin, R H, Lukashev, M & Gold, R 2011, ' Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway ', Brain, vol. 134, no. Pt 3, pp. 678-692 . https://doi.org/10.1093/brain/awq386
Brain, 134(Pt 3), 678-692. Oxford University Press
Brain, 134(Pt 3), 678-692. Oxford University Press
Inflammation and oxidative stress are thought to promote tissue damage in multiple sclerosis. Thus, novel therapeutics enhancing cellular resistance to free radicals could prove useful for multiple sclerosis treatment. BG00012 is an oral formulation
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 34
Introduction: Triglycerides from chylomicron and VLDL particles are cleared in the periphery through Lipoprotein lipase (LPL). LPL is negatively regulated by Angiopoietin-like proteins 3 and 4 (Angptl3/4) and Apolipoprotein C3 (apoC3). CAT-2003 is an
Autor:
Michael Zimmer, Dominic Picarella, Feng Liu, Pradeep Bista, Diana Lee, Chi Vu, Michael Jirousek
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 34
Introduction: CAT-2003 is an orally active small molecule that inhibits SREBP maturation (nSREBP-1 and nSREBP-2) and activation of SREBP-target genes, including PCSK9. CAT-2003 mechanism of action was studied in HepG2 cells and in the transgenic ApoE